Anti-TNFRSF18(r) [T9P4G4*D7]

TNFRSF18 is the receptor for TNFSF18. It seems to be involved in interactions between activated T-lymphocytes and endothelial cells and in the regulation of T-cell receptor-mediated cell death.

Contributors

Inventor Institute
Ayham Alnabulsi Vertebrate Antibodies Limited
Cat. #: 152676
Tool sub type: Primary antibody
Unit size: 100 ug
Research Fields: Cancer;Cell signaling and signal transduction;Immunology
Application: ELISA ; IHC ; WB
Target: Tumor Necrosis Factor Receptor Superfamily, Member 18 (TNFRSF18-cell membrane)
Reactivity: Human
Clone: T9P4G4*D7
Host: Mouse
Class: Monoclonal
Product description: TNFRSF18 is the receptor for TNFSF18. It seems to be involved in interactions between activated T-lymphocytes and endothelial cells and in the regulation of T-cell receptor-mediated cell death.
Conjugation: Unconjugated
Isotype: IgG2b kappa
Immunogen: Peptide Sequence TEDARSCQFP
Myeloma used: P3X63Ag8.653
Target background: TNFRSF18 is the receptor for TNFSF18. It seems to be involved in interactions between activated T-lymphocytes and endothelial cells and in the regulation of T-cell receptor-mediated cell death.
Format: Liquid
Concentration: 0.8 mg/ml
Storage buffer: PBS with 0.02% azide
Storage conditions: -20° C
Shipping conditions: Dry ice

Images

View Gallery
Western blot analysis using Anti-TNFRSF18 (cell membrane) clone T9P4G4*D7

Related Tools for Antibodies

Cat. # Tool Name
151019 Anti-Mos [S3.1] Key Info View Tool
151022 Anti-IL12 [1-1A4] Key Info View Tool
151028 Anti-Cytochrome P450 2C2, 2B1/2 [h7] Key Info View Tool
151038 Anti-Cytochrome P450 4A2, 4A3 [Clo4] Key Info View Tool
151018 Anti-Mos [R38.1] Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.